SCSA Diagnostics

SCSA Diagnostics is a private U.S. fertility diagnostics company focused on sperm DNA fragmentation testing for male infertility assessment. Its core commercial offering is the SCSA Test, a sperm chromatin structure assay that measures DNA Fragmentation Index and high DNA stainability-related abnormalities to help evaluate the likelihood of successful conception naturally or through assisted reproductive techniques such as IVF and ICSI. The company positions SCSA as a clinically established, research-backed assay and operates what it describes as the only CLIA-approved laboratory for this specific test. SCSA Diagnostics serves patients, physicians, clinics, and hospitals through physician-ordered and patient-requested testing workflows. The business is best characterized as a specialized reproductive health diagnostics laboratory rather than a therapeutics developer.